Article metrics

Download PDFPDF

Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study

 

Online download statistics by month:

Online download statistics by month: August 2020 to January 2023

AbstractFullPdf
Aug 202019920054
Sep 202010910930
Oct 2020444415
Nov 2020595918
Dec 202028279
Jan 2021252512
Feb 2021484613
Mar 202127278
Apr 202139397
May 202126269
Jun 202129303
Jul 2021343410
Aug 2021494917
Sep 2021282811
Oct 2021303023
Nov 2021202013
Dec 202122223
Jan 202220207
Feb 202229296
Mar 202225256
Apr 2022313319
May 2022575613
Jun 202230304
Jul 202219191
Aug 202222224
Sep 202223239
Oct 202225256
Nov 2022272712
Dec 2022773
Jan 202316167
Total11471147352